Loading…
← CockpitCompetitor Analysis › 688596.SS Shanghai GenTech Co., Ltd. Class AOpen in the cockpit ↗

Shanghai GenTech Co., Ltd. Class A688596.SSCompetitor analysis, valuation and peers

China · CNY·Industrials›Miscellaneous Commercial Services

Shanghai builder of gas and chemical supply systems for chip fabs, and supplier of electronic specialty gases and operations services.

Momentum strong 74
Mkt cap
$2.37B
US dollars, full cap
Free float
72%
of shares outstanding
$/day
$177M
20-day average traded
Fwd P/E
68.2×
forward earnings
ROIC−WACC
-6.0 pp
WACC 8.9%
Hurdle
n/a
no reverse DCF
Next earnings
155 days
22 Apr 2027
Close · CNYCN¥50.07
1D-0.5%
1W-11.0%
1M+4.6%
3M-30.3%
6M+4.3%
YTD+58.3%
1Y+58.9%
ATR %8.9%
52w lowhigh43.5% off high

What Shanghai GenTech does

Shanghai builder of gas and chemical supply systems for chip fabs, and supplier of electronic specialty gases and operations services.

Earns mainly from designing and installing the piping, gas cabinets and chemical supply systems inside chip and display plants, a project business whose timing follows customers' factory building. Over time it adds recurring income by supplying electronic specialty gases, equipment components and maintenance to the same fabs.

Products and services

  • Process-critical systems (gas and chemical supply, clean-roo
  • Electronic specialty gases and advanced materials
  • Semiconductor equipment components (quartz, silicon carbide)
  • Operations and maintenance services

Customers

  • Chip makers and semiconductor fabs
  • Display, solar and other advanced-manufacturing pl

Where it sits in the supply chain

  • Semiconductor equipment and materials
  • Process-critical systems
  • Gas and chemical supply systems and…

What could go right

  • Chip-fab construction in China
  • Domestic substitution in specialty gases and parts

What could go wrong

  • Fab capex cycles
  • Project-based revenue timing

Moat: narrow (customer qualification, installed base). Systems are qualified inside fabs and then supplied with gases and maintenance; recurring fab ties.

Headquarters: Shanghai, China · Founded: 2009 · Employees: 2,458

Named competitors

Shanghai GenTech at a glance

Size Shanghai GenTech (688596.SS) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $2.37B, the 1012th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥50.07 on 18 Nov 2026.

Performance Over six months the shares gained 4.3%, against +1.4% for the median peer and -20.0% for the China market (cap-weighted) — 10th highest of 21 in its peer set.

Growth Revenue grew 4.0% over the last twelve months (peer median +21.4%); the operating margin is 1.8% (peer median 21.6%).

Valuation It trades at 68.2× forward earnings against a peer median of 20.3× (4th most expensive of 18).

Capital Return on invested capital runs 6.0 points below its cost of capital (8.9% WACC).

Next results Next results expected around 22 Apr 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026688596.SS 102Peer median 101
Six months, rebased to 100: Shanghai GenTech against the median of its 20 peers (local-currency closes).

Shanghai GenTech financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥5.46BCN¥4.91BCN¥5.46BCN¥3.83BCN¥2.70B
Revenue growth—-10%+42%+42%—
Gross profitCN¥1.19BCN¥949MCN¥1.35BCN¥979MCN¥706M
EBITDAn/aCN¥333MCN¥696MCN¥467MCN¥285M
Net incomeCN¥337MCN¥136MCN¥528MCN¥401MCN¥259M
Free cash flow-CN¥34.3M-CN¥84.4M-CN¥2.52M-CN¥219M-CN¥408M
Capital expenditureCN¥267MCN¥366MCN¥424MCN¥360MCN¥260M
Total debtCN¥4.02BCN¥3.62BCN¥1.50BCN¥1.07BCN¥1.17B

Quarterly statements and history in the cockpit →

Shanghai GenTech competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%300140601965KWSVVX001267SAGILITY41946053763264IWG7799TICHURN6257603061688796688690012750IGILPLX688596.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Shanghai GenTech is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%0×50×100×601965KWSVVX001267SAGILITY41946053763264IWGHURN688796688690IGILPLX688596.SSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Shanghai GenTech is the large dot.

Shanghai GenTech competitors and peer comparison

Head to head with its named competitors (688596.SS vs 688268.SS vs 688106.SS vs AI.PA)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Shanghai GenTech 688596.SS$2.37B+4%+4%2%68.2×n/a
Guangdong Huate Gas 688268.SS$1.82B-50%+27%13%53.1×34.7%
Jinhong Gas 688106.SS$1.12B-38%+15%2%64.2×n/a
Air Liquide AI.PA$133B+15%-1%21%29.4×18.5%

How Shanghai GenTech compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Shanghai GenTech against its 20 peers (data as of 18 Nov 2026)
Measure688596.SSPeer medianRank in peer set
1-month return+4.6%-3.8%8th highest of 21
6-month return+4.3%+1.4%10th highest of 21
Distance from 52-week high-43.5%-25.1%6th lowest of 21
Revenue growth (TTM)+4.0%+21.4%6th lowest of 20
Operating margin1.8%21.6%3rd lowest of 21
Forward P/E68.2×20.3×4th most expensive of 18
ROIC minus cost of capital-6.0 pp+2.0 pp4th lowest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Shanghai GenTech 688596.SSChina$2.37B+4%+4%2%68.2×n/an/a
CECEP Environmental Protection 300140.SZChina$2.37B-23%-2%23%n/a-1.9%+26.0%
China Automotive Engineering Research Institute 601965.SSChina$2.31B-11%+12%24%13.8×-4.7%+7.9%
KWS SAAT SE & Co KGaA KWS.DEGermany$2.30B-11%-1%13%12.7×-6.0%+4.4%
V2X VVXUnited States$2.45B+9%+13%4%11.7×-0.5%+26.3%
Hui Lyu Ecological Technology Groups 001267.SZChina$2.28B-68%+90%10%133.5×n/an/a
Sagility SAGILITY.NSIndia$2.26B+7%+28%18%17.0×11.2%+19.5%
Visional 4194.TJapan$2.50B+33%+24%25%20.3×-2.1%+28.2%
Jiangsu Boqian New Materials Stock 605376.SSChina$2.52B-46%+76%20%33.2×n/an/a
Ardentec 3264.TWOTaiwan$2.17B-26%+32%30%11.3×n/an/a
International Workplace IWG.LUnited Kingdom$2.60B+14%0%4%22.2×34.1%+3.3%
Heron Neutron Medical 7799.TWTaiwan$2.15B+56%n/a-5,319%355.2×n/an/a
TIC Solutions TICUnited States$2.15B+14%+39%-1%n/a32.6%n/a
Huron Consulting HURNUnited States$2.68B+58%+12%12%16.7×-3.4%+14.3%
Sigurd Microelectronics 6257.TWTaiwan$2.10B-28%+18%24%11.3×n/an/a
JHT Design 603061.SSChina$2.68B-31%+93%34%n/a41.1%+30.4%
Biocytogen Pharmaceuticals (Beijing) 688796.SSChina$2.09B-33%+40%24%73.0×31.0%+41.1%
Suzhou Nanomicro Technology 688690.SSChina$2.08B-1%+26%25%51.5×33.2%+35.2%
S-1 012750.KSSouth Korea$2.73B+36%+1%7%23.8×-6.4%+5.4%
International Gemological Institute IGIL.NSIndia$2.05B+33%+21%58%26.0×16.3%+37.6%
Pluxee PLX.PAFrance$2.75B+4%+1%28%9.2×n/an/a

Questions

Who are Shanghai GenTech's main competitors?
Named competitors: Huate Gas (688268.SS), Jinhong Gas (688106.SS), Air Liquide (AI.PA). The cockpit's measured peer set (industry) also includes CECEP Environmental Protection (300140.SZ), China Automotive Engineering Research Institute (601965.SS), KWS SAAT SE & Co KGaA (KWS.DE), V2X (VVX), Hui Lyu Ecological Technology Groups (001267.SZ), Sagility (SAGILITY.NS).
Is Shanghai GenTech expensive compared with its peers?
On forward p/e it trades at 68.2× against a peer median of 20.3×, 4th most expensive of 18 in its peer set.
How has Shanghai GenTech stock performed?
Over six months to 18 Nov 2026 the shares returned +4.3% against +1.4% for the median peer; over one year +58.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.